How Do Individual Funding Requests Work for Medical Cannabis on the NHS?

Medical cannabis has been a topic of significant interest and debate in the UK since its rescheduling in 2018. While it remains Additional info https://highstylife.com/how-do-i-find-a-legit-medical-cannabis-clinic-in-the-uk/ legal to prescribe under specific conditions, accessing it on the NHS is far from straightforward. Patients and clinicians often need to navigate a complex system involving specialist prescribing rules, cautious NHS funding, and the use of unlicensed cannabis-based medicines (CBPMs). This article breaks down how individual funding requests (IFRs) work for medical cannabis on the NHS, demystifying the process step-by-step, clarifying the difference between legality and NHS funding, and providing useful resources for further support.
The 2018 Rescheduling of Medical Cannabis: What Changed?
Before 2018, cannabis-based products were generally not prescribed legally in the UK’s NHS clinics. The landmark change came in November 2018 when the Home Office rescheduled cannabis-derived medicinal products (CDMPs) to Schedule 2 under the Misuse of Drugs Regulations. This reclassification allowed specialist doctors to legally prescribe medical cannabis, under strict controls, essentially opening the door for NHS prescribing for the first time.

However, the rescheduling changed legality — not NHS funding policy. In simple terms, doctors in certain specialties can now legally prescribe cannabis-based medicines, but the NHS generally does not routinely fund them. This distinction often causes confusion among patients and even some healthcare professionals.
NHS Funding vs Legal Prescribing: What Patients Need to Know
Legal prescribing of medical cannabis: Allowed only by certain specialists in the UK following 2018 rescheduling. This means doctors such as neurologists, pain specialists, or pediatric epilepsy consultants can prescribe cannabis-based medicines, but only for conditions where licensed or unlicensed products are deemed clinically appropriate.

NHS funding of medical cannabis: Mostly *not* routinely provided. NICE and NHS England have issued guidance strongly cautioning against widespread NHS adoption due to limited robust evidence on efficacy and cost-effectiveness. Therefore, while a specialist might write a prescription, the costs are usually not covered by the NHS. Patients often have to pay out-of-pocket or try an Individual Funding Request.

In other words, the law allows certain doctors to prescribe medical cannabis, but the NHS normally does not pay for it.
Specialist-Only Prescribing Rules on the NHS
Medical cannabis prescriptions on the NHS are restricted to specialist doctors on the General Medical Council (GMC) Specialist Register. These specialists include but are not limited to:
Neurologists – often for epilepsy Pain specialists – for chronic pain conditions Pediatric consultants – in limited instances for childhood epilepsy
GPs and non-specialists cannot prescribe cannabis-based products for medical use under current NHS rules. This limitation means patients seeking medical cannabis through the NHS must first secure a referral to an appropriate specialist.
Unlicensed Cannabis-Based Medicines (CBPMs) and NHS Caution
Most cannabis-based medicines currently prescribed in the UK are unlicensed medicines. Unlike fully licensed medicines approved by the Medicines and Healthcare products Regulatory Agency (MHRA), these unlicensed cannabis products do not have a marketing authorisation. This status raises further complexities:
No standardized dosing or formulations. NHS organisations are cautious about prescribing unlicensed medicines due to liability risks and lack of large-scale clinical evidence. NHS England and NICE guidance often advise against routine funding of unlicensed CBPMs except in highly exceptional circumstances.
Note: This cautious approach is not unique to cannabis; NHS prescribing of unlicensed medicines is generally restricted and subject to clinical reviews.
What Exactly Is an Individual Funding Request (IFR)?
An Individual Funding Request is a formal application made by a clinician on behalf of a patient to request NHS funding for a treatment that is not routinely funded or commissioned. IFRs are specific to patients with exceptional clinical circumstances and can include requests for medical cannabis when standard pathways do not support NHS prescription.

IFRs are considered at a local commissioning level (e.g., Clinical Commissioning Groups – CCGs, or Integrated Care Boards – ICBs) and involve a rigorous assessment process. The broad criteria include:
The patient’s clinical condition and need justify the treatment. No suitable alternative treatment on the NHS is available. The treatment is likely to provide significant clinical benefit. The request meets local criteria for funding exceptional treatments. How to Make an Individual Funding Request for Medical Cannabis
To submit an IFR for medical cannabis on the NHS, the following steps generally apply:
Referral to a specialist who can assess whether medical cannabis is clinically appropriate. Specialist assessment where the clinician documents why standard treatments have failed or are unsuitable. Clinic submits an IFR to the local NHS funding authority, providing clinical evidence supporting the request. NHS panel decision: The IFR panel considers clinical evidence, cost, alternatives, and exceptional factors. Outcome: Approval may lead to NHS funding of the prescribed medical cannabis; denial means patients must consider privately funded options.
Note: The IFR process can be slow, taking weeks <strong>two-tier healthcare uk</strong> https://smoothdecorator.com/how-can-i-spot-overconfident-medical-cannabis-marketing-in-the-uk/ or months, and success is not guaranteed.
Prices and Costs: What Patients Can Expect
Currently, there are no standard NHS prices for medical cannabis because it is not routinely commissioned. If you come across specific pricing for NHS-funded cannabis medicines in the future, always look for verified sources and exact figures before assuming costs.

Private prescriptions for medical cannabis typically cost thousands of pounds annually, depending on the product, dose, and supplier. To compare clinics offering private prescriptions, websites like medicalcannabis.co.uk provide directories and comparison tools.
Useful Resources for Patients Releaf.co.uk Explainer on NHS Medical Cannabis – a patient-friendly breakdown of NHS prescribing guidance and IFR processes. MedicalCannabis.co.uk Clinic Directory – compare clinics that offer private prescriptions and specialist consultations. Summary: What "NHS Funding Medical Cannabis" Really Means Aspect What Patients Need to Know Legal Prescribing Specialist doctors can legally prescribe medical cannabis since 2018 rescheduling NHS Funding Generally not routine; requires an Individual Funding Request for exceptional cases Prescribing Rights Restricted to GMC Specialist Register consultants only, no GP prescribing allowed Unlicensed Medicines Most cannabis medicines are unlicensed, making NHS funding and prescribing more cautious IFR Process Formal application triggered by a specialist when NHS funding exceptions are justified Costs No fixed NHS cost; private prescriptions can be expensive Final Thoughts
Understanding the difference between being able to legally prescribe medical cannabis and the reality of NHS funding is crucial for patients considering this treatment route. Individual Funding Requests offer a pathway for accessing medical cannabis on the NHS but require navigating complex criteria and processes with specialist support. For many, private prescription remains the only practical option currently.

For those interested in exploring options, consulting a specialist with experience in cannabis-based medicines is essential. Use reputable tools such as medicalcannabis.co.uk for clinic comparisons, and check out patient-friendly explanations like those at releaf.co.uk for a clearer understanding of how the NHS handles medical cannabis.

Remember: NHS access to medical cannabis isn’t straightforward, but knowing how individual funding requests work can empower patients to advocate effectively for their own healthcare.